|
WO2011006510A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Technical University Of Denmark |
Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
EP3388834B1
(en)
|
2013-03-15 |
2020-04-15 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
JP2014227338A
(ja)
*
|
2013-05-17 |
2014-12-08 |
キヤノン株式会社 |
インドシアニングリーン含有粒子およびその製造方法
|
|
CN112472699A
(zh)
|
2013-07-26 |
2021-03-12 |
种族肿瘤学公司 |
改善比生群及衍生物的治疗益处的组合方法
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015166986A1
(ja)
|
2014-04-30 |
2015-11-05 |
富士フイルム株式会社 |
リポソーム組成物及びその製造方法
|
|
AU2016219004A1
(en)
*
|
2015-02-13 |
2017-09-07 |
Op Nano Co., Ltd. |
Compositions and methods of tumor treatment utilizing nanoparticles
|
|
EP3265063A4
(en)
|
2015-03-03 |
2018-11-07 |
Cureport, Inc. |
Dual loaded liposomal pharmaceutical formulations
|
|
US9895313B2
(en)
|
2015-03-03 |
2018-02-20 |
Cureport, Inc. |
Combination liposomal pharmaceutical formulations
|
|
EP3270891A1
(en)
*
|
2015-03-17 |
2018-01-24 |
Leon-Nanodrugs GmbH |
Nanoparticles comprising a stabilized boronic acid compound
|
|
US10918599B2
(en)
*
|
2015-04-02 |
2021-02-16 |
The Research Foundation For The State University Of New York |
Serum-stable compositions and methods for light-triggered release of materials
|
|
JP6948313B6
(ja)
|
2015-09-17 |
2022-01-14 |
モデルナティエックス インコーポレイテッド |
治療剤の細胞内送達のための化合物および組成物
|
|
DK3372232T3
(da)
|
2015-11-02 |
2021-06-07 |
Fujifilm Corp |
Tumorterapeutisk middel omfattende gemcitabinliposomsammensætning og kit
|
|
WO2017087685A1
(en)
*
|
2015-11-20 |
2017-05-26 |
The Regents Of The University Of California |
Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
|
|
PL3386484T3
(pl)
|
2015-12-10 |
2022-07-25 |
Modernatx, Inc. |
Kompozycje i sposoby dostarczania środków terapeutycznych
|
|
JP6721907B2
(ja)
*
|
2015-12-18 |
2020-07-15 |
メディギア・インターナショナル株式会社 |
生体分解性腫瘍封止剤
|
|
LT3394030T
(lt)
|
2015-12-22 |
2022-04-11 |
Modernatx, Inc. |
Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
|
|
KR101630397B1
(ko)
*
|
2015-12-31 |
2016-06-24 |
한국과학기술원 |
항암제-인도시아닌 그린-리포좀 복합체를 포함하는 암 치료용 조성물
|
|
ES2897983T3
(es)
|
2016-02-15 |
2022-03-03 |
Univ Georgia |
Liposomas cargados con IPA-3 y procedimientos de uso de los mismos
|
|
WO2017200957A1
(en)
|
2016-05-16 |
2017-11-23 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
CN106474057A
(zh)
*
|
2016-12-02 |
2017-03-08 |
中国药科大学 |
一种奥沙利铂热敏长循环脂质体的蔗糖溶液制剂及其制备方法
|
|
US11331272B2
(en)
*
|
2017-01-18 |
2022-05-17 |
Temasek Life Sciences Laboratory Limited |
Hyperstabilized liposomes increase targeting of mitotic cells
|
|
EP4186888B1
(en)
|
2017-03-15 |
2025-11-26 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
CA3055653A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
WO2018170322A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
CA3058782A1
(en)
|
2017-04-03 |
2018-10-11 |
The Regents Of The University Of California |
Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
|
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
US10925831B2
(en)
*
|
2017-08-28 |
2021-02-23 |
Wake Forest University |
Liposomal formulations of platinum-acridine anticancer agents and methods thereof
|
|
EP3675817A1
(en)
|
2017-08-31 |
2020-07-08 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
|
US11110060B2
(en)
*
|
2017-10-25 |
2021-09-07 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for delivering pharmaceutical agents
|
|
US10606661B2
(en)
*
|
2017-12-15 |
2020-03-31 |
Rubrik, Inc. |
On-demand provisioning of customized developer environments
|
|
EP3731846A4
(en)
|
2017-12-29 |
2022-03-02 |
Wayne State University |
DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF INFECTION
|
|
ES2984147T3
(es)
|
2018-06-20 |
2024-10-29 |
Fujifilm Corp |
Medicamento combinado que comprende una composición liposómica de gemcitabina encapsulada y bloqueo de punto de control inmunitario
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2020061295A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
CA3113025A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Peg lipids and uses thereof
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
US20220000779A1
(en)
*
|
2018-12-06 |
2022-01-06 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions
|
|
RU2706427C1
(ru)
*
|
2018-12-27 |
2019-11-19 |
Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" |
Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата
|
|
TWI757739B
(zh)
*
|
2019-05-14 |
2022-03-11 |
國邑藥品科技股份有限公司 |
包含弱酸藥物之醫藥組成物及其用途
|
|
JP7253735B2
(ja)
|
2019-07-02 |
2023-04-07 |
パナソニックＩｐマネジメント株式会社 |
通過可否判定装置、通過管理システム、通過可否判定方法、及び、コンピュータプログラム
|
|
WO2021053163A1
(en)
|
2019-09-19 |
2021-03-25 |
Danmarks Tekniske Universitet |
Immune stimulating micelle composition
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
CA3155015A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
US20220364139A1
(en)
*
|
2019-09-24 |
2022-11-17 |
Pataigin, Llc |
Methods for determining growth and response
|
|
CN110571005B
(zh)
*
|
2019-09-27 |
2021-01-01 |
广西科技大学 |
一种固定化金属离子-磁性脂质体及其制备方法和应用
|
|
WO2022038605A1
(en)
*
|
2020-08-20 |
2022-02-24 |
Bionanosim (Bns) Ltd |
Lipid delivery systems for delivery of oxaliplatin palmitate acetate
|
|
KR102560135B1
(ko)
|
2020-12-04 |
2023-07-27 |
가톨릭대학교 산학협력단 |
표적 치료제의 효과적인 전달을 위한 다기능성 리포좀 조성물
|
|
US20240229154A9
(en)
|
2021-02-12 |
2024-07-11 |
Institut National de la Santé et de la Recherche Médicale |
Method for prognosis and treating a patient suffering from cancer
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
EP4306126A1
(en)
|
2021-03-08 |
2024-01-17 |
Eyegene Inc. |
Vaccine composition for preventing sars-cov-2
|